Costs in general practice
BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7065.1143b (Published 02 November 1996) Cite this as: BMJ 1996;313:1143- Michael Robertson
- General practitioner Marcham Road Family Health Centre, Abingdon, Oxfordshire OX14 1BT
EDITOR,—P D P Pharoah and W Hollingworth have calculated the potential costs and benefits of the increased use of statins to prevent deaths from coronary heart disease in a health authority.1 A similar and simpler calculation can be done for the patients of a British general practice.
The results of the west of Scotland coronary prevention study of pravastatin treatment in men with raised cholesterol concentration showed a headline reduction of 32% in cardiovascular mortality and 22% in all cause mortality after …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.